Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug patch testing in systemic cutaneous drug allergy.

Annick Barbaud1

  • 1Dermatology Department, Fournier Hospital, University Hospital of Nancy, 36 Quai de la Bataille, 54000 Nancy, France. a.barbaud@chu-nancy.fr

Toxicology
|March 16, 2005
PubMed
Summary

Drug patch testing aids in identifying causes of cutaneous adverse drug reactions (CADRs) and understanding their mechanisms. This method is safe, practical, and effective for diagnosing various drug-induced skin conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased risk of cutaneous lupus erythematosus flare during the late menopausal transition: A retrospective study of 64 women.

JAAD international·2026
Same author

Hypersensitivity to Excipients in Drugs: An EAACI Position Paper.

Allergy·2026
Same author

Immediate and delayed hypersensitivity to biologicals in children-A practical approach: An EAACI task force report.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Updated Treatment of Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease: How to Decide on Aspirin Therapy After Desensitization or Biologics? When? How? An EAACI Task Force Report.

Allergy·2026
Same author

Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy.

Allergy·2026
Same author

Prevention and management of syphilis in pregnant and perinatal women.

Infectious diseases now·2025

Area of Science:

  • Dermatology
  • Pharmacology
  • Clinical Immunology

Background:

  • Cutaneous adverse drug reactions (CADRs) pose a diagnostic challenge.
  • Patch testing is a valuable tool for investigating CADRs.

Purpose of the Study:

  • To evaluate the utility of drug patch testing in diagnosing CADRs.
  • To explore the pathophysiological mechanisms underlying CADRs.

Main Methods:

  • Patch testing with suspected drug compounds.
  • Utilizing commercialized drug forms, often diluted at 30% in petrolatum and/or water.
  • Performing tests within 6 months of the adverse drug reaction.

Main Results:

  • Drug patch tests are positive in approximately 32-50% of patients with CADRs.

Related Experiment Videos

  • The clinical relevance is high for specific CADR types like generalized eczema and fixed drug eruptions.
  • False positive results can occur, necessitating careful interpretation.

    • Conclusions:

    • Drug patch testing is a practical and safe method for diagnosing CADRs.
    • The test's effectiveness varies with the clinical presentation and the specific drug involved.
    • Further research is needed to determine the specificity and negative predictive value of drug patch tests.